More than 300 Fast-Growing Biopharmas Set the Stage for Launch Success with Veeva Vault PromoMats

Rhea-AI Summary

Veeva Systems reports significant adoption of its Vault PromoMats platform by over 300 emerging and mid-size biopharmaceutical companies globally, with more than 40 new clients in the U.S. in the past year. This software aids in streamlining medical, legal, and regulatory review processes and managing digital assets efficiently. The service is designed to support the growing demand for rapid content generation crucial for healthcare professionals. Industry leaders express satisfaction with the platform's capability to enhance compliance, visibility, and efficiency during product launches.

Positive

• More than 300 emerging and mid-size biopharma companies are using Vault PromoMats, indicating strong market demand.
• Over 40 new U.S. customers adopted the platform in the last year, signaling growing adoption rates.
• Vault PromoMats enhances efficiency in medical, legal, and regulatory review processes, crucial for fast-paced biopharma operations.

Negative

• None.

PLEASANTON, Calif., Feb. 9, 2022 /PRNewswire/ -- Hundreds of pharmaceutical and biotech companies are standardizing content operations on Veeva Vault PromoMats to build a foundation for effective go-to-market and launch execution. With over 300 emerging and mid-size Vault PromoMats customers globally, more than 40 in the U.S. adopted the commercial content platform within the last year to simplify medical, legal, and regulatory (MLR) review and digital asset management (DAM).

"Emerging biopharmas are achieving astounding breakthroughs in science and healthcare," said Pooja Ojala, vice president of commercial content at Veeva. "We're proud to collaborate with innovative, high-growth companies to deliver flexible, compliant content solutions that grow with them and drive efficiencies across their complete commercialization process."

With healthcare professionals (HCPs) now interacting across a growing number of channels, startup biopharmas need to generate more digital content, faster than ever. As they innovate to develop most new specialty treatments and launch products amidst greater competition, it is crucial to get the right content to HCPs quickly so they can help patients make informed decisions about their health.

Vault PromoMats improves visibility, control, and compliance throughout the digital content supply chain. It helps eliminate the need to move, duplicate, and manage assets across multiple systems, providing much-needed relief to smaller, agile companies whose key stakeholders carry the weight of multiple roles.  

Here's what emerging life sciences organizations are saying about Vault PromoMats:

"As we approach our first launch and beyond, we need a purpose-built content management system that can adapt to the unique commercialization needs of our specialized radiopharmaceutical," said Jason Kaufmann, Head of Marketing, Americas, Telix Pharmaceuticals. "With Veeva as a single source of truth for digital content, we have the foundation needed to be process savvy and effective as we expand globally."

"With Vault PromoMats, we can easily collaborate, share, and integrate digital content across our Veeva ecosystem," said Satish Kukkapalli, Associate Director, IT Product Manager, Ascendis Pharma. "This drives success right out the gate because we immediately gain valuable insights to inform more efficient content production and can implement changes quickly, as needed."

"Operating as a small team with limited resources, we need a compliant way to simplify digital content development and keep our operations agile as we grow," said Dana Smith, Director, U.S. Marketing, Calliditas Therapeutics. "Vault PromoMats helps us automate claims management and streamline MLR reviews to speed content turnaround for approvals, so we can get critical information to HCPs and patients in their preferred channel faster."

Emerging companies can learn more at veeva.com/vault-promomats-emerging-pharma/.

Additional Information
For more information on Veeva Vault PromoMats, visit veeva.com/PromoMats
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Contact:

Deivis Mercado Veeva Systems 925-226-8821 deivis.mercado@veeva.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/more-than-300-fast-growing-biopharmas-set-the-stage-for-launch-success-with-veeva-vault-promomats-301478400.html

SOURCE Veeva Systems

FAQ

What is Veeva Vault PromoMats?

Veeva Vault PromoMats is a commercial content platform designed to streamline medical, legal, and regulatory review processes for biopharmaceutical companies.

How many biopharma companies use Vault PromoMats?

Over 300 emerging and mid-size biopharma companies are currently using Veeva Vault PromoMats globally.

When was the press release about Vault PromoMats published?

The press release regarding Veeva Vault PromoMats was published on February 9, 2022.

What impact does Vault PromoMats have on the content supply chain?

Vault PromoMats improves visibility, control, and compliance throughout the digital content supply chain, making it easier for companies to manage their assets.

Why is Vault PromoMats important for startup biopharmas?

Vault PromoMats is crucial for startup biopharmas as it enables them to generate digital content quickly to support product launches in a competitive market.